BioLife Solutions, Inc.
BLFS
$25.41
-$1.09-4.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.07M | 25.42M | 23.94M | -3.42M | 21.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.07M | 25.42M | 23.94M | -3.42M | 21.39M |
| Cost of Revenue | 10.15M | 8.99M | 8.16M | -11.70M | 7.40M |
| Gross Profit | 17.92M | 16.43M | 15.79M | 8.27M | 13.99M |
| SG&A Expenses | 14.60M | 14.13M | 14.10M | 5.80M | 11.83M |
| Depreciation & Amortization | 699.00K | 708.00K | 702.00K | 3.00K | 683.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.16M | 26.54M | 25.16M | -4.81M | 21.81M |
| Operating Income | -89.00K | -1.12M | -1.22M | 1.39M | -418.00K |
| Income Before Tax | 703.00K | -15.71M | -434.00K | 1.54M | -551.00K |
| Income Tax Expenses | 82.00K | 126.00K | 14.00K | -131.00K | -80.00K |
| Earnings from Continuing Operations | 621.00K | -15.84M | -448.00K | 1.67M | -471.00K |
| Earnings from Discontinued Operations | -- | -- | -- | 10.79M | -1.23M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 621.00K | -15.84M | -448.00K | 12.46M | -1.70M |
| EBIT | -89.00K | -1.12M | -1.22M | 1.39M | -418.00K |
| EBITDA | 1.25M | 260.00K | 166.00K | 2.76M | 1.90M |
| EPS Basic | 0.01 | -0.33 | -0.01 | 0.27 | -0.04 |
| Normalized Basic EPS | 0.01 | 0.00 | -0.01 | 0.02 | -0.01 |
| EPS Diluted | 0.01 | -0.33 | -0.01 | 0.26 | -0.04 |
| Normalized Diluted EPS | 0.01 | 0.00 | -0.01 | 0.02 | -0.01 |
| Average Basic Shares Outstanding | 47.93M | 47.80M | 47.13M | 46.65M | 46.18M |
| Average Diluted Shares Outstanding | 48.72M | 47.80M | 47.13M | 48.03M | 46.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |